16 Analysts Have This To Say About Gilead Sciences
Latest Ratings for GILD Date Firm Action From To Mar 2022 Barclays Maintains Underweight Mar 2022 RBC Capital Maintains Outperform Feb 2022 BMO Capital Downgrades Outperform Market Perform View More Analyst Ratings for GILD View the Latest Analyst Ratings read more